This enzyme contributes to the development of prostate cancer and its resistance to existing drugs. Previously, Lee’s team found that the substance was bioanine and effectively suppressed this enzyme, but it is difficult to use in medicine because of the weak absorption in the body.
In a new job, researchers with artificial intelligence aid examined the structure of the enzyme and created a improved drug improvement-116. It is better associated with enzyme and is well absorbed by the body due to special chemical changes.
The tests showed that HEAL-116 effectively inhibits the activity of the enzyme and slows down the growth of cancer cells both in itself and with other drugs. At the same time, the drug has no harmful effect on other processes in the body.
News -law materials cannot be equalized to the doctor’s prescription. Consult a specialist before deciding.
Source: Ferra
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.
